18 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Gainers

Novavax, Inc. NVAX stock rose 41.26% to $15.20 during Tuesday's pre-market session. The most recent rating by Cantor Fitzgerald, on Mar 17, is at Overweight, with a price target of $16.

CNS Pharmaceuticals, Inc. CNSP stock moved upwards by 40.42% to $3.37.

Innate Pharma, Inc. IPHA shares increased by 22.09% to $5.25.

Athersys, Inc. ATHX shares surged 17.95% to $2.30.

Kitov Pharma, Inc. KTOV shares increased by 13.04% to $0.26.

Genprex, Inc. GNPX shares surged 11.89% to $2.54.

Aytu BioScience, Inc. AYTU stock surged 11.76% to $2.09.

DBV Technologies, Inc. DBVT shares moved upwards by 11.23% to $4.06. The most recent rating by Morgan Stanley, on Mar 18, is at Equal-Weight, with a price target of $4.

Tilray, Inc. TLRY stock rose 11.17% to $4.28. The most recent rating by Cantor Fitzgerald, on Mar 16, is at Neutral, with a price target of $5.

BioNTech, Inc. BNTX stock moved upwards by 10.11% to $56.50. The most recent rating by JP Morgan, on Mar 18, is at Neutral, with a price target of $33.

 

Losers

Milestone Pharmaceuticals, Inc. MIST stock declined 75.07% to $3.49 during Tuesday's pre-market session. The most recent rating by Piper Sandler, on Mar 24, is at Neutral, with a price target of $3.

Hoth Therapeutics, Inc. HOTH stock fell 19.79% to $3.

Biomerica, Inc. BMRA shares decreased by 10.34% to $7.89.

Ritter Pharmaceuticals, Inc. RTTR shares decreased by 8.29% to $0.41.

T2 Biosystems, Inc. TTOO shares fell 6.89% to $0.37.

CHF Solutions, Inc. CHFS shares fell 5.29% to $0.31.

Co-Diagnostics, Inc. CODX shares plummeted 4.33% to $9.05. According to the most recent rating by Maxim Group, on Mar 3, the current rating is at Hold.

Novan, Inc. NOVN shares plummeted 3.46% to $0.60. The most recent rating by H.C. Wainwright, on Jan 6, is at Buy, with a price target of $2.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversTrading IdeasHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!